CME Group (CME) Projected to Announce Earnings on Wednesday

19 Oct 2026, 05:56 by Sarita Garza · The Markets Daily

CME Group (NASDAQ:CME – Get Free Report) is expected to post its Q3 2026 results before the market opens on Wednesday, October 21st. Analysts expect the company to post earnings of $2.98 per share and revenue of $1.71 billion for the quarter. Parties can check the company’s upcoming Q3 2026 earnings overview page for the latest details on the call scheduled for Wednesday, October 21, 2026 at 8:30 AM ET.

CME Group (NASDAQ:CME – Get Free Report) last released its earnings results on Wednesday, July 22nd. The financial services provider reported $2.99 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.91 by $0.08. CME Group had a net margin of 63.30% and a return on equity of 15.60%. The company had revenue of $1.71 billion for the quarter, compared to analyst estimates of $1.68 billion. During the same period in the prior year, the business earned $2.96 EPS. The firm’s quarterly revenue was up .8% on a year-over-year basis. On average, analysts expect CME Group to post $12.30 EPS for the current fiscal year and $12.88 EPS for the next fiscal year.

CME Group Stock Performance

Shares of CME stock opened at $293.87 on Monday. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13. CME Group has a 52 week low of $218.31 and a 52 week high of $329.16. The stock has a market capitalization of $105.67 billion, a PE ratio of 24.93, a P/E/G ratio of 3.80 and a beta of 0.24. The firm has a 50 day moving average of $274.12 and a two-hundred day moving average of $270.58.

CME Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, September 25th. Stockholders of record on Wednesday, September 9th were given a dividend of $1.30 per share. The ex-dividend date of this dividend was Wednesday, September 9th. This represents a $5.20 dividend on an annualized basis and a dividend yield of 1.8%. CME Group’s dividend payout ratio is currently 44.11%.

Analyst Upgrades and Downgrades

Several analysts have recently issued reports on CME shares. Morgan Stanley increased their price objective on CME Group from $330.00 to $337.00 and gave the company an “overweight” rating in a research note on Friday, October 9th. Piper Sandler lowered their target price on CME Group from $329.00 to $295.00 and set an “overweight” rating for the company in a research note on Wednesday, July 15th. Wall Street Zen raised CME Group from a “strong sell” rating to a “sell” rating in a research note on Saturday, October 3rd. Wells Fargo & Company upped their price target on CME Group from $301.00 to $315.00 and gave the stock an “overweight” rating in a report on Wednesday. Finally, Weiss Ratings raised CME Group from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Thursday, October 8th. Nine equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and three have assigned a Sell rating to the company. According to MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $292.94.

Get Our Latest Report on CME Group

Insiders Place Their Bets

In other CME Group news, Director Elizabeth Cook sold 500 shares of the stock in a transaction that occurred on Monday, September 14th. The shares were sold at an average price of $280.11, for a total value of $140,055.00. Following the sale, the director directly owned 17,916 shares of the company’s stock, valued at approximately $5,018,450.76. This represents a 2.72% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, CEO Terrence Duffy sold 15,000 shares of the stock in a transaction that occurred on Thursday, September 10th. The shares were sold at an average price of $274.44, for a total transaction of $4,116,600.00. Following the completion of the sale, the chief executive officer directly owned 40,630 shares in the company, valued at approximately $11,150,497.20. This represents a 26.96% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 0.30% of the stock is currently owned by company insiders.

About CME Group

(Get Free Report)

CME Group Inc operates global derivatives marketplaces that provide trading, clearing and settlement services for futures and options contracts. Its products cover major asset classes, including interest rates, equity indexes, foreign currencies, agricultural commodities, energy and metals. The company also provides market data, benchmark information and related services used by financial institutions, corporations, producers, investors and other market participants.